TSHA
#2136
Taysha Gene Therapies, Inc. - Common Stock
5.7 0 USD
+0.06%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+5.95%
Variación mensual
-5.00%
Variación en los últimos 6 meses
+15.62%
Cambio anual
+126.19%
Cierres anteriores
5.3 8
Open
5.7 0
Mínimo
5.7 0
High
5.7 0
Volumen
140
Financials
- Market Capitalization 1.64 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-11.76
Relación precio/flujo de caja
187.65
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2124 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.51 USD | +2.36% | +11.47% | +31.25% | +149.43% | 1.68 B USD | ||
| 2128 |  GHRS GH Research PLC - Ordinary Shares | 26.77 USD | +5.60% | +0.22% | +32.13% | +89.05% | 1.66 B USD | ||
| 2145 |  INVA Innoviva, Inc. - Common Stock | 21.74 USD | -2.12% | -2.29% | -5.35% | +22.00% | 1.60 B USD | ||
| 2146 |  VIR Vir Biotechnology, Inc. - Common Stock | 9.49 USD | -2.37% | -6.04% | +10.09% | +58.70% | 1.60 B USD |